Article
Plasma exchange removes glycosphingolipid in Fabry disease
Article first published online: 2 JUN 2005
DOI: 10.1002/ajmg.1320070308
Copyright © 1980 Wiley-Liss, Inc., A Wiley Company
Additional Information
How to Cite
Pyeritz, R. E., Ullman, M. D., Moser, A. B., Braine, H. G., Moser, H. W. and Optiz, J. M. (1980), Plasma exchange removes glycosphingolipid in Fabry disease. American Journal of Medical Genetics, 7: 301–307. doi: 10.1002/ajmg.1320070308
Publication History
- Issue published online: 2 JUN 2005
- Article first published online: 2 JUN 2005
- Manuscript Revised: 21 JUN 1980
- Manuscript Received: 16 MAY 1980
- Abstract
- References
- Cited By
Keywords:
- lysosome;
- storage disease;
- glycosphingolipid;
- plasma exchange;
- Fabry disease;
- ceramide trihexosidase deficiency;
- α-galactosidase deficiency;
- X-linked inheritance;
- high performance liquid chromatography
Abstract
In a man with Fabry disease, basal plasma glycosphingolipid (GSL) levels were determined by high-performance liquid chromatography (HPLC). A series of three alternate-day plasma exchanges transiently lowered plasma ceramide trihexoside (CTH) to normal. A total of 70 μmoles of CTH were removed by eight plasma exchanges. If future studies show that pathologic tissue accumulations of CTH are reduced by plasma exchange, then long-term repetitive plasma exchange could be used as treatment until enzyme replacement is practical.

1552-4833/asset/olbannerleft.gif?v=1&s=dc5513758e0602016bfe88cd52afd78bf862aab9)
1552-4833/asset/olbannerright.gif?v=1&s=c3d8a0f0a45667625907578ec1e0f011cbe060b1)
1552-4833/asset/cover.gif?v=1&s=9818ec8c89d0772bf0e752b15694c460afb83f9f)